The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma

Clinical trial NCT01655888 · UNKNOWN

Trial details

NCT number: NCT01655888
Sponsor: Azienda Ospedaliera Universitaria Senese
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Mesothelioma

Start date: 2012-07-01
Primary completion: 2014-01-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.